GLP-1 Envy Was Just the Beginning
A Super Bowl ad by Hims & Hers sells the idea that everyone should want to be billionaire-healthy.…
15,821$
0,13%
Echtzeit-Aktienkurs Hims & Hers Health Inc.
Bid:
Ask:
Nachrichten zur Hims & Hers Health Inc. Aktie
Hims Super Bowl commercial talks wealth-health gap, rich people live longer
Hims & Hers turns the spotlight on a controversial conversation.…
Grails $700 blood test may detect cancer early with 2 tubes of blood
A new Super Bowl ad from Hims & Hers telehealth touts a blood test for cancer. Its $700, but its…
Hims & Hers responds to FDA pressure, pulls knockoff Wegovy drug launch after regulatory threats
Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved semaglutide compounds and…
Hims & Hers stops selling weight loss pill days after unveiling it
Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with stakeholders across the…
Hims & Hers drops plan for knockoff of Novo Nordisk’s new Wegovy weight loss pill
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday…
Hims & Hers drops plan for knockoff of Novo Nordisks new Wegovy weight loss pill
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday…
Hims & Hers drops plan for knockoff of Novo Nordisks new Wegovy weight loss pill
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday…
Hims & Hers drops plan for knockoff of Novo Nordisks new Wegovy weight loss pill
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday…
Regulatory Scrutiny Puts Hims And Hers GLP 1 Growth Story To The Test
Hims & Hers Health (NYSE:HIMS) is facing heightened regulatory and legal scrutiny over its compounded semaglutide weight loss pill, launched…
Hims & Hers scraps copycat Wegovy weight-loss pill after probe
The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss…
Hims & Hers Health to stop offering copycat Wegovy pill
…
Hims & Hers will stop selling compounded version of Novo’s obesity pill
Hims & Hers will stop selling what it claims to be a cheaper, compounded version of Novo Nordisks obesity pill…
Hims & Hers pulls copycat weight-loss pill after threats of legal action
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of…
Hims & Hers to Stop Offering Copycat Wegovy Weight-Loss Pill
Just two days after launching a copycat version of the new Wegovy weight-loss pill, Hims & Hers Health Inc. said…
Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
Hims & Hers said in a statement on Saturday that it will stop offering access to the compounded semaglutide pill…
Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown
Feb 7 () - Hims & Hers said ?in a statement ?on Saturday that it will ?stop offering ?access to…
Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown By Reuters
Hims & Hers to stop offering compounded semaglutide pill after FDA crackdown…
U.S. signals crackdown on compounded weight-loss drugs; Hims shares tumble
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims…
HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of Wegovy
FDA will take “decisive steps” to thwart companies from mass marketing unapproved, compounded versions of GLP-1 drugs…
FDA to restrict GLP-1 ingredients used in non?approved compounded drugs
The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims…
FDA to Restrict Copycat Weight Loss Drugs Sold by Pharma Rivals
The US Food and Drug Administration said it would crack down on copycat weight loss drugs like those marketed by…
FDA to restrict GLP-1 ingredients used in non?approved compounded drugs
The U.S. Food and Drug Administration said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs…
Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill
Hims & Hers also said it’s selling a cancer-detection test that’s featured in its Super Bowl ad, which plays like…
Hims And Hers Weight Loss Bet Faces GLP 1 Legal And FDA Tests
Hims & Hers Health launched a compounded semaglutide pill within its personalized weight loss offering, entering the oral GLP-1 market…
Hims $49 weight-loss pill rattles investor case for cash-pay obesity market
Hims & Hers gambit to sell a $49 compounded version of Novo Nordisks Wegovy pill is rattling obesity shares, sparking…
Hims & Hers launches Wegovy knockoff pill, drugmaker Novo Nordisk vows to sue
The announcement from Hims is the latest example of the companys efforts to capitalize on obesity drugs like Wegovy, which…
Hims & Hers shares tick lower after Novos legal threat
Hims & Hers stock ticked lower Friday after Novo Nordisk said its newly announced Wegovy pill copy was illegal and…
FDAs Makary pledges crackdown on mass marketing of illegal copycat drugs in wake of Hims Wegovy pill push
With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the…
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
Novo Nordisk has also spoken out strongly against Hims & Hers compounded Wegovy pill, with CEO Maziar Mike Doustdar telling…
Hims & Hers Stock Tanks. It May Be Losing Its Weight-Loss Battle With Novo.
Novo Nordisk stock has dived this week, dragged down by a weak sales outlook and the launch of a Wegovy…